...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: What’s the point - short interest doubled lol

Fuzz,

It could have been to buy a small $20 pizza, loaded with toppings for the important boardroom meeting.    Hopefully everyone was full... more importantly, I wonder if they tipped the driver?

:)

Long

 

Share
New Message
Please login to post a reply